Quartet Medicine Lands $17,000,000 Series A Round

  • Feed Type
  • Date
    10/27/2014
  • Company Name
    Quartet Medicine
  • Mailing Address
    Undisclosed Cambridge, MA 02139 USA
  • Company Description
    Quartet Medicine is a private, biotechnology company focused on discovering and developing novel treatments for chronic pain and inflammation. Human genetics and preclinical target validation data point to increased tetrahydrobiopterin (BH4) as a critical mediator of peripheral nerve dysfunction and immune cell regulation.
  • Website
    http://www.quartetmedicine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Quartet plans to use the funding to advance its lead program targeting the modulation of tetrahydrobiopterin (BH4) synthesis through human proof-of-concept studies.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy